Literature DB >> 20231393

Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.

Moran G Goren1, Shiri Navon-Venezia, Inna Chmelnitsky, Yehuda Carmeli.   

Abstract

All of the carbapenem-resistant Escherichia coli (CREC) isolates identified in our hospital from 2005 to 2008 (n = 10) were studied. CREC isolates were multidrug resistant, all carried bla(KPC-2), and six of them were also extended-spectrum beta-lactamase producers. Pulsed-field gel electrophoresis indicated six genetic clones; within the same clone, similar transferable bla(KPC-2)-containing plasmids were found whereas plasmids differed between clones. Tn4401 elements were identified in all of these plasmids.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20231393      PMCID: PMC2876404          DOI: 10.1128/AAC.01359-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 beta-lactamase production and loss of an outer membrane protein.

Authors:  P D Stapleton; K P Shannon; G L French
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-beta-lactamase VIM-1.

Authors:  Vivi Miriagou; Eva Tzelepi; Dimitra Gianneli; Leonidas S Tzouvelekis
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

3.  In vivo acquisition of high-level resistance to imipenem in Escherichia coli.

Authors:  Laurent Poirel; Claire Héritier; Colette Spicq; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

4.  OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.

Authors:  Laurent Poirel; Sophie Marqué; Claire Héritier; Christine Segonds; Gérard Chabanon; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

5.  CTX-M-2 and a new CTX-M-39 enzyme are the major extended-spectrum beta-lactamases in multiple Escherichia coli clones isolated in Tel Aviv, Israel.

Authors:  Inna Chmelnitsky; Yehuda Carmeli; Azita Leavitt; Mitchell J Schwaber; Shiri Navon-Venezia
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

6.  A general method for detecting and sizing large plasmids.

Authors:  B M Barton; G P Harding; A J Zuccarelli
Journal:  Anal Biochem       Date:  1995-04-10       Impact factor: 3.365

7.  The use of analytical isoelectric focusing for detection and identification of beta-lactamases.

Authors:  A Mathew; A M Harris; M J Marshall; G W Ross
Journal:  J Gen Microbiol       Date:  1975-05

8.  Dissemination of the metallo-beta-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia.

Authors:  Anton Y Peleg; Clare Franklin; Jan M Bell; Denis W Spelman
Journal:  Clin Infect Dis       Date:  2005-10-31       Impact factor: 9.079

9.  Multilocus sequence typing reveals a lack of diversity among Escherichia coli O157:H7 isolates that are distinct by pulsed-field gel electrophoresis.

Authors:  Anna C Noller; M Catherine McEllistrem; O Colin Stine; J Glenn Morris; David J Boxrud; Bruce Dixon; Lee H Harrison
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

10.  Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli.

Authors:  R Odeh; S Kelkar; A M Hujer; R A Bonomo; P C Schreckenberger; J P Quinn
Journal:  Clin Infect Dis       Date:  2002-06-24       Impact factor: 9.079

View more
  16 in total

1.  Molecular characteristics of KPC-producing Enterobacteriaceae at the early stage of their dissemination in Poland, 2008-2009.

Authors:  Anna Baraniak; Anna Grabowska; Radosław Izdebski; Janusz Fiett; Małgorzata Herda; Katarzyna Bojarska; Dorota Żabicka; Marta Kania-Pudło; Grazyna Młynarczyk; Zofia Żak-Puławska; Waleria Hryniewicz; Marek Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Escherichia coli from Italy producing OXA-48 carbapenemase encoded by a novel Tn1999 transposon derivative.

Authors:  Tommaso Giani; Viola Conte; Vincenzo Di Pilato; Richard Aschbacher; Cordula Weber; Clara Larcher; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

3.  Correlations of antibiotic use and carbapenem resistance in enterobacteriaceae.

Authors:  Milena McLaughlin; M Renee Advincula; Michael Malczynski; Chao Qi; Maureen Bolon; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

4.  Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.

Authors:  Azita Leavitt; Yehuda Carmeli; Inna Chmelnitsky; Moran G Goren; Itzhak Ofek; Shiri Navon-Venezia
Journal:  Antimicrob Agents Chemother       Date:  2010-03-29       Impact factor: 5.191

5.  Complete sequence of a conjugative incn plasmid harboring blaKPC-2, blaSHV-12, and qnrS1 from an Escherichia coli sequence type 648 strain.

Authors:  Jun-Jie Li; Chang-Seop Lee; Ji-Fang Sheng; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2014-09-02       Impact factor: 5.191

6.  Molecular epidemiology of KPC-producing Escherichia coli: occurrence of ST131-fimH30 subclone harboring pKpQIL-like IncFIIk plasmid.

Authors:  Jessica A O'Hara; Fupin Hu; Chulsoo Ahn; Jeremy Nelson; Jesabel I Rivera; Anthony W Pasculle; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2014-05-12       Impact factor: 5.191

7.  KPC-Like Carbapenemase-Producing Enterobacteriaceae Colonizing Patients in Europe and Israel.

Authors:  A Baraniak; R Izdebski; J Fiett; M Herda; L P G Derde; M J M Bonten; A Adler; Y Carmeli; H Goossens; W Hryniewicz; C Brun-Buisson; M Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

8.  Emergence of Escherichia coli sequence type 131 isolates producing KPC-2 carbapenemase in China.

Authors:  Jia Chang Cai; Rong Zhang; Yan Yan Hu; Hong Wei Zhou; Gong-Xiang Chen
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

Review 9.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

10.  Involvement of MarR and YedS in carbapenem resistance in a clinical isolate of Escherichia coli from China.

Authors:  Douglas M Warner; Qiwen Yang; Valérie Duval; Minjun Chen; Yingchun Xu; Stuart B Levy
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.